RELAPSED ACUTE MYELOID LEUKEMIA (AML)

Clinical trials for RELAPSED ACUTE MYELOID LEUKEMIA (AML) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED ACUTE MYELOID LEUKEMIA (AML) trials appear

Sign up with your email to follow new studies for RELAPSED ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New 'Living Drug' trial targets tough blood cancers

Disease control Not yet recruiting

This is a first-in-human study testing a new type of CAR T-cell therapy for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, genetically…

Matched conditions: RELAPSED ACUTE MYELOID LEUKEMIA (AML)

Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

RELAPSED ACUTE MYELOID LEUKEMIA (AML)

Get alerted when new RELAPSED ACUTE MYELOID LEUKEMIA (AML) trials appear

New 'Living Drug' trial targets tough blood cancers